Skip to main content
Ophthalmic manifestations of perinatally acquired HIV in a US cohort of long-term survivors
Published Web Location
http://bjo.bmj.com/content/99/5/650.full.pdf+htmlNo data is associated with this publication.
Abstract
Background/aims
To determine the ophthalmic manifestations of HIV in a cohort of long-term survivors of perinatally acquired HIV.Methods
Twenty-two patients with perinatally acquired HIV who were aged ≥12 years were prospectively studied at a university clinic. They underwent complete ophthalmic examinations and fundus photography. Their medical histories, medications and CD4 counts were abstracted from the medical records. To evaluate for keratoconjunctivitis sicca, both HIV patients and 44 healthy controls (matched by age, gender and contact lens wear) underwent Schirmer testing and ocular surface staining.Results
Nine male and 13 female HIV patients with mean age of 16.6 years (SD, 3.4) were examined. Of the 22 HIV patients, 21 had been treated with highly active antiretroviral therapy (HAART). Only one patient had a CD4 count nadir of <200 cells/µL. The mean visual acuity of the eyes of the HIV subjects was 20/22 (SD, 1.6 lines). No patient had cytomegalovirus retinitis. Four of the 22 (18%) HIV patients had strabismus. HIV subjects and controls had similar rates of abnormal Schirmer (9% and 14%, p=0.62) and ocular staining scores (p=0.29).Conclusions
In the post-HAART era, long-term survivors of perinatally acquired HIV exhibited little vision-threatening disease, but had a high prevalence of strabismus.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.